+
Open data
-
Basic information
Entry | ![]() | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Title | Cryo-EM structure of URAT1 in complex with benzbromarone | |||||||||
![]() | ||||||||||
![]() |
| |||||||||
![]() | protein structure / STRUCTURAL PROTEIN / TRANSPORT PROTEIN | |||||||||
Function / homology | ![]() Organic anion transport / renal urate salt excretion / urate transport / urate metabolic process / urate transmembrane transporter activity / organic anion transport / monoatomic ion transport / PDZ domain binding / brush border membrane / cellular response to insulin stimulus ...Organic anion transport / renal urate salt excretion / urate transport / urate metabolic process / urate transmembrane transporter activity / organic anion transport / monoatomic ion transport / PDZ domain binding / brush border membrane / cellular response to insulin stimulus / apical plasma membrane / response to xenobiotic stimulus / membrane / plasma membrane Similarity search - Function | |||||||||
Biological species | ![]() ![]() | |||||||||
Method | single particle reconstruction / cryo EM / Resolution: 3.5 Å | |||||||||
![]() | Zhao Y / Yu Z | |||||||||
Funding support | ![]()
| |||||||||
![]() | ![]() Title: Molecular mechanism of drug inhibition of URAT1. Authors: Zhuoya Yu / Tuo Hu / Jiawei Su / Jun Zhao / Renjie Li / Qiao Ma / Qihao Chen / Qinru Bai / Yanli Dong / Pu Yuan / Na Li / Xuejun Cai Zhang / Yan Zhao / ![]() Abstract: Hyperuricemia, characterized by elevated serum urate levels, is a key factor in the pathogenesis of gout. URAT1 is essential for renal urate reabsorption and has emerged as a critical therapeutic ...Hyperuricemia, characterized by elevated serum urate levels, is a key factor in the pathogenesis of gout. URAT1 is essential for renal urate reabsorption and has emerged as a critical therapeutic target for managing hyperuricemia. However, the precise transport mechanism and the inhibitory effects of uricosuric drugs on URAT1 remain unclear. Here, we present structures of the double-mutant rat homolog of URAT1 in complex with its substrate urate, and the clinical drugs benzbromarone, lesinurad, verinurad, and sulfinpyrazone. The urate-bound structure elucidates key residues involved in recognizing urate, while the structures bound with drugs clearly demonstrate the distinct binding mode of each drug with URAT1. These drugs stabilize URAT1's inward-facing state, blocking conformational transitions. Additionally, critical interactions essential for its conformational transition are identified. These findings provide a molecular framework for understanding the physiological function of URAT1 and for developing more efficacious therapies to treat hyperuricemia. | |||||||||
History |
|
-
Structure visualization
Supplemental images |
---|
-
Downloads & links
-EMDB archive
Map data | ![]() | 59.8 MB | ![]() | |
---|---|---|---|---|
Header (meta data) | ![]() ![]() | 14.7 KB 14.7 KB | Display Display | ![]() |
Images | ![]() | 36.7 KB | ||
Filedesc metadata | ![]() | 5.8 KB | ||
Others | ![]() ![]() | 59.4 MB 59.4 MB | ||
Archive directory | ![]() ![]() | HTTPS FTP |
-Validation report
Summary document | ![]() | 991.1 KB | Display | ![]() |
---|---|---|---|---|
Full document | ![]() | 990.7 KB | Display | |
Data in XML | ![]() | 12 KB | Display | |
Data in CIF | ![]() | 14.3 KB | Display | |
Arichive directory | ![]() ![]() | HTTPS FTP |
-Related structure data
Related structure data | ![]() 9j73MC ![]() 9j72C ![]() 9j75C ![]() 9j76C M: atomic model generated by this map C: citing same article ( |
---|---|
Similar structure data | Similarity search - Function & homology ![]() |
-
Links
EMDB pages | ![]() ![]() |
---|---|
Related items in Molecule of the Month |
-
Map
File | ![]() | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
Voxel size | X=Y=Z: 0.85 Å | ||||||||||||||||||||||||||||||||||||
Density |
| ||||||||||||||||||||||||||||||||||||
Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
Details | EMDB XML:
|
-Supplemental data
-Half map: #2
File | emd_61192_half_map_1.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Projections & Slices |
| ||||||||||||
Density Histograms |
-Half map: #1
File | emd_61192_half_map_2.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Projections & Slices |
| ||||||||||||
Density Histograms |
-
Sample components
-Entire : structure of URAT1
Entire | Name: structure of URAT1 |
---|---|
Components |
|
-Supramolecule #1: structure of URAT1
Supramolecule | Name: structure of URAT1 / type: complex / ID: 1 / Parent: 0 / Macromolecule list: #1 |
---|---|
Source (natural) | Organism: ![]() ![]() |
-Macromolecule #1: Solute carrier family 22 member 12
Macromolecule | Name: Solute carrier family 22 member 12 / type: protein_or_peptide / ID: 1 / Number of copies: 1 / Enantiomer: LEVO |
---|---|
Source (natural) | Organism: ![]() ![]() |
Molecular weight | Theoretical: 60.251273 KDa |
Recombinant expression | Organism: ![]() |
Sequence | String: MAFPELLDRV GGRGRFQLLQ AVALVTPILW VTTQSMLENF SAAVPHHRCW VPLLDNSTSQ ASIPGDFGRD VLLAVSIPPG PDQRPHQCL RFRQPQWQLI ESNTTATNWS DADTEPCEDG WVYDHSTFRS TIVTTWDLVC DSQALRPMAQ SIFLAGILVG A AVCGHASD ...String: MAFPELLDRV GGRGRFQLLQ AVALVTPILW VTTQSMLENF SAAVPHHRCW VPLLDNSTSQ ASIPGDFGRD VLLAVSIPPG PDQRPHQCL RFRQPQWQLI ESNTTATNWS DADTEPCEDG WVYDHSTFRS TIVTTWDLVC DSQALRPMAQ SIFLAGILVG A AVCGHASD RFGRRRVLTW SYLLVSVSGT IAALMPTFPL YCLFRFLVAS AVAGVMMNTA SLLMEWTSAQ AGPLMMTLNA LG FSFGQVL TGSVAYGVRS WRMLQLAVSA PFFLFFVYSW WLPESARWLI TVGRLDQSLR ELQRVAAVNR RKAEADTLTV EVL RSAMQE EPNGNQAGAR LGTLLHTPGL RLRTFISMLC WFAFGFTFFG LALDLQALGS NIFLLQALIG IVDLPVKMGS LLLL SRLGR RLCQASSLVL PGLCILANIL VPREMGILRS SLAVLGLGSL GAAFTCVTIF SSELFPTVIR MTAVGLGQVA ARGGA MLGP LVRLLGVYGS WLPLLVYGVV PVLSGLAALL LPETKNLPLP DTIQDIQKQS VKKVTHDIAG GSVLKSARL UniProtKB: Solute carrier family 22 member 12 |
-Macromolecule #2: [3,5-bis(bromanyl)-4-oxidanyl-phenyl]-(2-ethyl-1-benzofuran-3-yl)...
Macromolecule | Name: [3,5-bis(bromanyl)-4-oxidanyl-phenyl]-(2-ethyl-1-benzofuran-3-yl)methanone type: ligand / ID: 2 / Number of copies: 1 / Formula: R75 |
---|---|
Molecular weight | Theoretical: 424.083 Da |
Chemical component information | ![]() ChemComp-R75: |
-Experimental details
-Structure determination
Method | cryo EM |
---|---|
![]() | single particle reconstruction |
Aggregation state | particle |
-
Sample preparation
Buffer | pH: 7.5 |
---|---|
Vitrification | Cryogen name: ETHANE |
-
Electron microscopy
Microscope | FEI TITAN KRIOS |
---|---|
Image recording | Film or detector model: GATAN K3 (6k x 4k) / Average electron dose: 60.0 e/Å2 |
Electron beam | Acceleration voltage: 300 kV / Electron source: ![]() |
Electron optics | Illumination mode: OTHER / Imaging mode: BRIGHT FIELD / Nominal defocus max: 2.0 µm / Nominal defocus min: 1.0 µm |
Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |